Key Statistics for RO
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (CHF) (ttm)
|Est. EPS (CHF) (12/2013)
|Est. PEG Ratio
|Market Cap (M CHF)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|Cash Dividend (CHF)
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for RO
- Net Income (M/CHF)
Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.
More Company Profile & Key Executives for RO
|Franz B HumerChairman||Severin SchwanChief Executive Officer|
|Alan HippeChief Financial Officer||Urs JaisliChief Compliance Officer|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries